Go to Home

NEWS

Recent deals, Alliances & news

ReGen Therapeutics Plc has announced that it has signed an agreement with Eczacibasi Ilac Pazarlama A.S.*, appointing ReGen Therapeutics as the exclusive distributor of Eczacibasi's nutritional supplement Colostrinin™ in the Rupublic of Turkey. 26 January 2009
AmpliMed Corporation, a cancer therapeutics company, announced today that it has entered into a license agreement with leading Korean-based pharmaceutical company Handok Pharmaceuticals for exclusive rights to its investigational cancer therapeutic Amplimexon(R)in Korea. September 10, 2008
Ascend Therapeutics Partners with Valeant Pharmaceuticals to promote Migranal® migraine product to OB/GYN physicians, October 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal® to OB/GYNs
BIO (Biotechnology Industry Organization) has selected ProPharma for the 5th consecutive year to assist in organizing the 5th annual BIO-Asia Partnering Conference in Tokyo, January, 28-29 2008
Gemin X Biotechnologies and Leo Pharma
Gemin X Biotechnologies licenses world wide rights to GMX1777, a novel pro drug therapeutic for the treatment of refractory solid tumors and Lymphomas from Leo Pharma May 2007
Regen and Metagenics Adobe Acrobat PDF Document
ReGen signs first commercial deal for Colostrinin
Cytogen Corporation and Inpharma AS Adobe Acrobat PDF Document
Cytogen Corporation has licensed the exclusive North American rights to CAPHOSOL® from Inpharma AS.
Asterand and BTG Adobe Acrobat PDF Document
BTG licenses analgesic compounds from Asterand
Sanochemia and Avigen Adobe Acrobat PDF Document
Avigen partners Sanochemia's tolperisone for the North American market.
Cambridge Laboratories and IDM Adobe Acrobat PDF Document
IDM and Cambridge Laboratories sign agreement for Junovan™
Miikana Therapeutics and Roche Adobe Acrobat PDF Document
Miikana licenses Phase II anticancer compound from Roche
BioAsia Partnering ConferenceBIO (Biotechnology Industry Organization) has selected ProPharma to assist in organizing the 3rd annual BioAsia Partnering Conference scheduled for January 31-Feb 1, 2006.
Pfizer and Meridica Adobe Acrobat PDF Document
Pfizer's acquisition of Meridica
Enzon Pharmaceuticals, Inc. and Pharmagene
Cystic fibrosis treatment development collaboration
Replidyne, Inc and Sequoia Sciences Adobe Acrobat PDF Document
Compound/access screening collaboration
Daiichi Pharmaceuticals and Rigel Pharmaceuticals Adobe Acrobat PDF Document
Cancer focused drug discovery partnership
Cerylid Biosciences and Anadys Pharmaceuticals Adobe Acrobat PDF Document
Natural product chemistry collaboration
Metabolex and Yamanouchi Adobe Acrobat PDF Document
Diabetes target discovery partnership
+44 1293 425 300